Spinnaker Trust Processa Pharmaceuticals, Inc. Transaction History

Spinnaker Trust

  • $1.61 Billion
  • Q3 2024

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 02, 2024
BUY
$0.18 - $0.84 $13,835 - $64,566
76,865 New
76,865 $26,000

About Processa Pharmaceuticals, Inc.

PCSA Quotes by TradingView
  • Ticker PCSA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 15,856,200
  • Market Cap $18.4M
  • Description
  • Processa Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, focuses on the development of drug products for the treatment of patients with unmet medical needs in the United States. Its lead product candidate is PCS499, an oral tablet that is in Phase 2B clinical trials for the treatment of ulcerative and non-ulcerative necrobiosi...
More about PCSA
Track This Portfolio

Track Spinnaker Trust Portfolio

Follow Spinnaker Trust and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Spinnaker Trust, based on Form 13F filings with the SEC.

News

Stay updated on Spinnaker Trust with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email